BALSALAZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Balsalazide, and what generic alternatives are available?
Balsalazide is a drug marketed by Apotex, Carnegie, Hikma, Novitium Pharma, Zydus Lifesciences, and Aarxion Anda Hlding. and is included in six NDAs.
The generic ingredient in BALSALAZIDE is balsalazide disodium. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Balsalazide
A generic version of BALSALAZIDE was approved as balsalazide disodium by APOTEX on December 28th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BALSALAZIDE?
- What are the global sales for BALSALAZIDE?
- What is Average Wholesale Price for BALSALAZIDE?
Summary for BALSALAZIDE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for BALSALAZIDE |
| DailyMed Link: | BALSALAZIDE at DailyMed |
US Patents and Regulatory Information for BALSALAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 077883-001 | Dec 28, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Novitium Pharma | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 077807-001 | Dec 28, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Carnegie | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 219422-001 | Apr 3, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | BALSALAZIDE DISODIUM | balsalazide disodium | CAPSULE;ORAL | 077806-001 | Dec 28, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
